163 related articles for article (PubMed ID: 33259333)
1. Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
Feng W; Wang Y; Chen S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):24333-24344. PubMed ID: 33259333
[TBL] [Abstract][Full Text] [Related]
2. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Ma D; Jiang YZ; Liu XY; Liu YR; Shao ZM
Breast Cancer Res Treat; 2017 Feb; 162(1):39-48. PubMed ID: 28093659
[TBL] [Abstract][Full Text] [Related]
5. The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
Ge Y; Wei F; Du G; Fei G; Li W; Li X; Chu J; Wei P
BMC Cancer; 2021 Mar; 21(1):240. PubMed ID: 33678158
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
Dong Z; Pei S; Zhao Y; Guo S; Wang Y
Crit Rev Eukaryot Gene Expr; 2020; 30(2):101-109. PubMed ID: 32558489
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract][Full Text] [Related]
9. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral heterogeneity contributes to the chemotherapy prognosis of breast cancer.
Li Y; Wang M; Yang S; Kuang L; Tao X; Yang J; Zhao W; Zhang J
J Cancer Res Ther; 2022 Sep; 18(5):1268-1275. PubMed ID: 36204872
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
Wu M; Wang Y; Liu H; Song J; Ding J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338286
[TBL] [Abstract][Full Text] [Related]
12. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
Front Immunol; 2021; 12():693314. PubMed ID: 34177954
[TBL] [Abstract][Full Text] [Related]
13.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
14. A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing.
Yin H; Guo R; Zhang H; Liu S; Gong Y; Yuan Y
Front Immunol; 2021; 12():728169. PubMed ID: 34745098
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.
Huang M; He M; Guo Y; Li H; Shen S; Xie Y; Li X; Xiao H; Fang L; Li D; Peng B; Liang L; Yu J; Kuang M; Xu L; Peng S
Clin Cancer Res; 2020 Sep; 26(18):4947-4957. PubMed ID: 32527942
[TBL] [Abstract][Full Text] [Related]
16. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
[No Abstract] [Full Text] [Related]
17. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis.
Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J
J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559
[TBL] [Abstract][Full Text] [Related]
19. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
20. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
